Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using rTMS to treat mood and cognitive symptoms of depression

Official title: Multisite Repetitive Transcranial Magnetic Stimulation for Mood, Cognitive Impairment, Anhedonia and Disordered Sleep in Depressive Disorder

Run by Jagiellonian University · NCT06363981 · Data updated 2026-11-12

This study is testing if a new way of using brain stimulation can help improve mood and thinking problems in people with unipolar and bipolar depression who haven't found relief from regular treatments.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment90 (estimated)
SponsorJagiellonian University
Academic / other
Locations1 site (Krakow)
StatusRecruiting
StartedMay 20, 2024
Main results expectedDecember 2026
Study endsApril 2027
Registry record updatedOctober 15, 2024
Trial IDNCT06363981 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals experiencing moderate to severe depressive episodes without psychotic symptoms.

Probably not a fit

Patients with psychotic symptoms, recent suicidal ideations, or contraindications to rTMS will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of repetitive transcranial magnetic stimulation (rTMS) on mood, cognitive impairment, anhedonia, and sleep disorders in patients with unipolar depression and bipolar disorder. It aims to compare the therapeutic potential of multi-site stimulation over the left dorsolateral prefrontal cortex (DLPFC) and dorsomedial prefrontal cortex (dmPFC) against stimulation over the DLPFC alone and a sham treatment. The study includes patients with moderate to severe depressive episodes and assesses their symptoms using standardized scales. By exploring this novel approach, the study seeks to optimize rTMS as a treatment option for those who are resistant to conventional pharmacotherapy.

Why it matters

Potential benefit: If successful, this study could provide a new effective treatment option for patients suffering from depression and related cognitive impairments.

How similar studies have gone: While some studies have explored rTMS for depression, this multi-site approach is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* severe or moderate depressive episode (according to international classification of diseases (ICD)-10) without psychotic symptoms at the time of inclusion
* Hamilton Depression Rating Scale between between 20 and 35 points at inclusion
* The score in the Athens Insomnia Scale eight or more
* The score of three or more points in items 4 and 21 of the Beck Depressions Inventory 2
* Complaining about problems with memory and concentration timely related with the onset of depression

Exclusion Criteria:

* Contraindications to transcranial magnetic stimulation, including ferromagnetic elements in head, pregnancy and epilepsy
* Psychotic symptoms at the time of inclusion
* Suicidal ideations and/or attempts within three months prior to inclusion

Where it's running

  • The Education of Research and Development Center, Babinski Clinical Hospital
    Krakow, Poland
    Recruiting

Study contacts

  • Principal investigator: Wojciech Korzeniowski, MD — The Education of Research and Development Center, Babinski Clinical Hospital
  • Study coordinator: Wojciech Korzeniowski, MD
  • Email: wojciech.korzen@gmail.com
  • Phone: +48 12 652 45 20

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.